Displaying drugs 3601 - 3625 of 5212 in total
Idanpramine
Experimental
Istiratumab
Istiratumab is under investigation in clinical trial NCT02399137 (A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer).
Investigational
Imaradenant
Imaradenant is under investigation in clinical trial NCT03381274 (Oleclumab (MEDI9447) Egfrm NSCLC Novel Combination Study).
Investigational
Itanapraced
Investigational
Ifebemtinib
Investigational
Ixmyelocel-T
Ixmyelocel-T is an expanded, autologous multicellular therapy cultured from bone-marrow mononuclear cells. Developed by Vericel Corporation, it is being investigated for cardiomyopathy.
Investigational
Idrevloride
Investigational
Ilixadencel
Investigational
Mibefradil
Mibefradil was withdrawn from the market in 1998 because of potentially harmful interactions with other drugs.
Investigational
Withdrawn
Imipramine oxide
Experimental
Ioglicic acid
Experimental
Indium In-111 altumomab pentetate
Investigational
Incomplete Freund's adjuvant
Investigational
Isoamyl alcohol
Experimental
Tryptamine
Experimental
Nanaomycin D
Experimental
Matched Iupac: … (11R,15S,17S)-4-hydroxy-17-methyl-12,16-dioxatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1(10),3(8), …
KF-1601
Investigational
gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine
Experimental
Fluocortolone caproate
Experimental
Matched Iupac: … 2-[(1S,2R,3aS,3bS,5S,9aR,9bS,10S,11aS)-5-fluoro-10-hydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH, …
Matched Mixtures name: … ULTRALAN KREM, 10 G ... ULTRALAN POMAT, 10 GR ... ULTRAPROCT SUPOZITUAR, 10 ADET …
Matched Mixtures name: … ULTRALAN KREM, 10 G ... ULTRALAN POMAT, 10 GR ... ULTRAPROCT SUPOZITUAR, 10 ADET …
Isoquercitrin
Isoquercitrin is under investigation in clinical trial NCT04622865 (Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19).
Investigational
Idursulfase beta
Idursulfase beta is under investigation in clinical trial NCT01645189 (Safety and Efficacy of Hunterase).
Investigational
Denenicokin
Denenicokin is under investigation in clinical trial NCT01152788 (Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma).
Investigational
Darleukin
Investigational
Respigam
Investigational
D2C7 immunotoxin
D2C7 immunotoxin (D2C7-IT) is an investigational dual-specific monoclonal antibody targeting EGFRwt and EGFRvIII with a genetically engineered form of the Pseudomonas exotoxin, PE38-KDEL. D2C7-IT is under investigation in clinical trial NCT04160494 (D2C7-IT With Atezolizumab for Recurrent Gliomas).
Investigational
Displaying drugs 3601 - 3625 of 5212 in total